
Perflow Medical Ltd
Investor Partner(s)
Perflow Medical's device is an interventional treatment and the medical industry’s first user-adjustable mechanical thrombectomy device, a breakthrough innovation that enables users to precisely control the diameter and radial force of the device, to immediately restore blood flow, and to retrieve the clot quickly in patients experiencing acute ischemic stroke.
Official Website
perflow.com/
×

EX-CO
Investor Partner(s)
EX.CO is a tech platform used by businesses and publishers worldwide to turn their content into an experience that engages their audience and delivers results
Official Website
ex.co/
×

Zapr
Investor Partner(s)
Zapr Media Labs is a technology company based out of India with the world's largest offline media consumption repository. Zapr bridges the gap between the offline and online worlds by enabling TV-to-Mobile audience engagement. They work across the value chain of media industry - right from media owners, broadcasters, advertisers, research companies and end consumers.
Official Website
www.zapr.in
×

Glints
Investor Partner(s)
Glints bridges the gap between education and employment by being a professional platform for young people focused on career discovery and development. It helps young people discover their passions and develop relevant career skills while empowering employers to attract the right talent more effectively.
Official Website
glints.com/
×

Qritive
Investor Partner(s)
Qritive provides an AI-powered cancer diagnosis solution to help doctors analyse both microscopy images and text from patient data. Enabling hospitals to impact cancer care at all levels, by bringing in higher accuracy, lowering costs and improving patient outcomes.
Official Website
www.qritive.com/
×

Proteona
Investor Partner(s)
Proteona is a new biomedical company based in Singapore and San Diego that is pioneering the use of DNA barcoded antibodies to provide both proteomic and genomic information from the same single cells. Proteona is a spin-off from the National University of Singapore (NUS) and the Agency for Science, Technology and Research’s (A*STAR). The platform is a comprehensive sample to answer service that enables users to phenotype cells using standard protein markers and gain a deeper understanding of cell activity based upon their gene expression profiles.
Official Website
proteona.com
×